(Q38771776)

6 September 2017

An oncogenic role of miR-592 in tumorigenesis of human colorectal cancer by targeting Forkhead Box O3A (FoxO3A). (English)

1 reference

6 September 2017

1 reference

1 reference

Qi Fu

1

1 reference

6 September 2017

Yong Du

2

1 reference

6 September 2017

Chun Yang

3

1 reference

6 September 2017

Dong Zhang

4

1 reference

6 September 2017

Ningmei Zhang

5

1 reference

6 September 2017

Xiaoming Liu

6

1 reference

6 September 2017

William C Cho

7

1 reference

6 September 2017

Yinxue Yang

8

1 reference

6 September 2017

language of work or name

English

0 references

publication date

11 May 2016

1 reference

Expert Opinion on Therapeutic Targets

6 September 2017

1 reference

6 September 2017

20

1 reference

6 September 2017

7

1 reference

6 September 2017

771-782

1 reference

6 September 2017

Cancer statistics, 2015

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1181753

MicroRNAs as therapeutic targets in chemoresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1181753

A role for cancer stem cells in therapy resistance: cellular and molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1181753

Molecular mechanisms of drug resistance and its reversal in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1181753

FOXO3-mediated up-regulation of Bim contributes to rhein-induced cancer cell apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1181753

FoxO3a and disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1181753

Activating FOXO3a, NF-kappaB and p53 by targeting IKKs: an effective multi-faceted targeting of the tumor-cell phenotype?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1181753

MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1181753

FOXO3a loss is a frequent early event in high-grade pelvic serous carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1181753

Unregulated miR-96 induces cell proliferation in human breast cancer by downregulating transcriptional factor FOXO3a

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1181753

FOXO3a modulates WNT/β-catenin signaling and suppresses epithelial-to-mesenchymal transition in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1181753

FOXO3a and β-catenin co-localization: double trouble in colon cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1181753

Role of the forkhead transcription factor FOXO-FOXM1 axis in cancer and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1181753

FoxO proteins: regulation and molecular targets in liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1181753

Remarkably reduced expression of FoxO3a in metaplastic colorectum, primary colorectal cancer and liver metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1181753

miRNA-155 modulates the malignant biological characteristics of NK/T-cell lymphoma cells by targeting FOXO3a gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1181753

MicroRNA-30d regulates cardiomyocyte pyroptosis by directly targeting foxo3a in diabetic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1181753

MicroRNA-96 inhibits FoxO3a function in IPF fibroblasts on type I collagen matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1181753

miR-194 regulated AGK and inhibited cell proliferation of oral squamous cell carcinoma by reducing PI3K-Akt-FoxO3a signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1181753

Inhibition of p38alpha unveils an AMPK-FoxO3A axis linking autophagy to cancer-specific metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1181753

The regulation and function of miR-21-FOXO3a-miR-34b/c signaling in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1181753

More, more, more: downregulation of a MK5-FoxO3a-mir34b/c pathway further increases c-Myc levels in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1181753

Up-regulation of miR-592 correlates with tumor progression and poor prognosis in patients with colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1181753

A new mathematical model for relative quantification in real-time RT-PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1181753

The DEAD box protein p68: a crucial regulator of AKT/FOXO3a signaling axis in oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1181753

Inhibition of colon cancer growth by docosahexaenoic acid involves autocrine production of TNFα.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1181753

Aldose reductase inhibition suppresses colon cancer cell viability by modulating microRNA-21 mediated programmed cell death 4 (PDCD4) expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1181753

Targeted therapy against chemoresistant colorectal cancers: Inhibition of p38α modulates the effect of cisplatin in vitro and in vivo through the tumor suppressor FoxO3A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1181753

PTEN-regulated AKT/FoxO3a/Bim signaling contributes to reactive oxygen species-mediated apoptosis in selenite-treated colorectal cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1181753

Evaluating the evidence for targeting FOXO3a in breast cancer: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1181753

The AMPK-FoxO3A axis as a target for cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1181753

FOXC2 promotes colorectal cancer proliferation through inhibition of FOXO3a and activation of MAPK and AKT signaling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1181753

β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1181753

miR-153 supports colorectal cancer progression via pleiotropic effects that enhance invasion and chemotherapeutic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1181753

microRNA-224 promotes cell proliferation and tumor growth in human colorectal cancer by repressing PHLPP1 and PHLPP2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1181753

Down-regulation of miR-21 Induces Differentiation of Chemoresistant Colon Cancer Cells and Enhances Susceptibility to Therapeutic Regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1181753

MicroRNA-23a antisense enhances 5-fluorouracil chemosensitivity through APAF-1/caspase-9 apoptotic pathway in colorectal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14728222.2016.1181753

10.1080/14728222.2016.1181753

21 January 2018

Identifiers

DOI

1 reference

6 September 2017

1 reference